Clinical Trial Update: Safety and Tolerability of Memantine in Moderate to Severe Alzheimer's Disease [Phase 3]

View source ↗

Summary

Phase 3 trial assessing safety and tolerability of memantine in moderate to severe Alzheimer's disease; the study was terminated and results were posted in 2012…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Namenda (memantine)

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Alzheimer's Disease | Phase 3 | Status: TERMINATED | Results posted: 2012-08-29